COMMUNIQUÉS West-GlobeNewswire

AMAG Pharmaceuticals and Endoceutics Announce Presentation at the 2018 Annual Meeting of The North American Menopause Society on the Effect of Time Since Menopause, Age and Previous Hormone Therapy on the Response to Intravaginal Prasterone

04/10/2018 - 14:00

Study Suggests that While All Postmenopausal Women Benefit from Treatment with Prasterone (INTRAROSA ® ), Women Experience Greatest Relief of Moderate to Severe Dyspareunia when started on INTRAROSA ® within One to Two [...]

BIOMODEX Announces New Training Solution for Left Atrial Appendage Closure (LAACS)

04/10/2018 - 13:57

3D-printed, patient-specific heart marks the company’s move into interventional cardiology BOSTON, Oct. 04, 2018 (GLOBE NEWSWIRE) -- BIOMODEX, an innovative medical technology company using proprietary 3D printing [...]

Tauriga Sciences Inc. Enters into MOU to Acquire California Based Revenue Generating OMEGA-3 Product and Technology

04/10/2018 - 13:45

Los Angeles, CA, Oct. 04, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and [...]

Pain Therapeutics Announces $3.5 Million NIH Grant Award to Study Alzheimer’s Disease

04/10/2018 - 13:30

– NIH Grant Will Enable Clinical Tests of PTI-125 in Patients with Alzheimer’s Disease – – Phase II Study Initiation Expected Q4 2018 – AUSTIN, Texas, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: [...]

SIGA Enters into Cooperative Research and Development Agreement with U.S. Army Medical Research Institute of Infectious Disease to Evaluate the Efficacy of TPOXX® as a Post-Exposure Prophylactic for Smallpox

04/10/2018 - 13:30

NEW YORK, Oct. 04, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it has entered into a [...]

Integrated Cannabis Company, Inc. Announces Positive Results from Clinical Study of X-SPRAYS Sleep Product

04/10/2018 - 13:30

VANCOUVER, British Columbia, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Integrated Cannabis Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (“ Integrated Cannabis ”) is pleased to announce the successful completion and positive results [...]

Study Opens of BeyondSpring’s Lead Asset, Plinabulin, and Nivolumab + Ipilimumab in Small-Cell Lung Cancer

04/10/2018 - 13:30

Rutgers Trial Aims to Demonstrate Reduction in Immune-Related Adverse Events, While Adding to Anti-Cancer Immune Effects for Patients NEW YORK, Oct. 04, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) ( [...]

Theratechnologies Announces Financial Results for the Third Quarter of 2018

04/10/2018 - 13:30

MONTREAL, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced its financial results for the third quarter ended August 31, 2018. Third quarter 2018 financial highlights [...]

Theratechnologies annonce ses résultats financiers du troisième trimestre de 2018

04/10/2018 - 13:30

MONTRÉAL, 04 oct. 2018 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies ») (TSX : TH) a annoncé aujourd’hui ses résultats financiers pour le troisième trimestre clos le 31 août 2018. Faits saillants [...]

Clinical Laserthermia Systems to Exhibit MRI-Guided Laser Thermal Therapy System at 12th Interventional MRI Symposium

04/10/2018 - 13:00

Minimally Invasive, Non-Cooled Laser Fiber Eliminates External Cooling & Helps Reduce Procedure Times FRAMINGHAM, Mass., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc . (CLS Americas [...]

Zafgen to Present Data from Multiple Nonclinical, IND-Enabling Studies of ZGN-1258 at the 2018 Foundation for Prader-Willi Research Family Conference

04/10/2018 - 13:00

Nonclinical data for ZGN-1258 reproduce efficacy seen in first generation candidate for PWS Data show highly improved safety profile Company also presenting study design of PATH for PWS natural history study co- [...]

Cyclacel Pharmaceuticals and MD Anderson Cancer Center Announce Strategic Alliance to Study Novel Cyclacel Medicines in Hematological Malignancies

04/10/2018 - 13:00

Multi-product agreement builds on long-term clinical collaboration in hematological malignancies BERKELEY HEIGHTS, N.J. and HOUSTON, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC, Nasdaq [...]

Landmark AdVance Study Shows Adenovirus Burden Correlates with Mortality in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients

04/10/2018 - 13:00

– First Study to Show that Adenovirus Area Under the Curve is an Optimal Indicator of Clinical Outcomes in Adenovirus Infection – DURHAM, N.C., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a [...]

PCI Biotech: Final results of the rights issue

04/10/2018 - 12:44

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG OR SOUTH AFRICA, OR ANY OTHER [...]

Nightstar Therapeutics to Present at Chardan Genetic Medicines Conference

04/10/2018 - 12:05

WALTHAM, Mass. and LONDON, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Nightstar Therapeutics plc (NASDAQ:NITE), a clinical-stage gene therapy company developing treatments for rare inherited retinal diseases, today announced [...]

Zealand Pharma enrolls first patient in Phase 3 trial with glepaglutide for the treatment of short bowel syndrome

04/10/2018 - 11:33

Press release - No. 21/2018 Zealand Pharma enrolls first patient in Phase 3 trial with glepaglutide for the treatment of short bowel syndrome The Phase 3 registration trial has enrolled the first short bowel syndrome ( [...]

FIT Biotech Oy: FIT Biotech files a patent application for using its GTU-based technology against the Chikungunya virus

04/10/2018 - 10:01

FIT Biotech Oy Company release 04.10.2018 at 11:00 AM EET FIT Biotech files a patent application for using its GTU-based technology against the Chikungunya virus FIT Biotech Oy ("Company", FITBIO: FN Finland) has filed [...]

Recording of the Second Quarter 2018 Investor Conference Webinar

04/10/2018 - 08:50

On October 3 AS „Olainfarm” organized its Investor Conference Online Webinar. During the webinar the Advisor to the Board of AS „Olainfarm” Salvis Lapiņš analyzed the financial results of second quarter 2018 and [...]

Ambu A/S: Ambu updates 2020 strategy and upgrades financial targets in connection with capital markets day 2018

04/10/2018 - 08:29

One year into the strategy period Ambu is ready to launch four new products and upgrade the long-term financial targets for 2020. Contact Lars Marcher, President & CEO, tel. +45 5136 2490, email: lm@ambu.com [...]